Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluticasone propionate + mupirocin is a topical combination medication used to treat bacterial skin infections with associated inflammation. It combines fluticasone propionate—a synthetic corticosteroid that reduces redness, swelling, and itching by suppressing the immune response—with mupirocin—an antibiotic that inhibits bacterial protein synthesis and kills bacteria responsible for skin infections. This combination is commonly prescribed for conditions such as infected eczema (eczema with secondary bacterial infection), dermatitis complicated by bacteria (such as impetigo), and other inflammatory skin disorders where both anti-inflammatory and antibacterial actions are needed. The product is available in cream or ointment form for external use only[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluticasone propionate + mupirocin.